DE69621649D1 - Verfahren zur herstellung von cefdinir - Google Patents

Verfahren zur herstellung von cefdinir

Info

Publication number
DE69621649D1
DE69621649D1 DE69621649T DE69621649T DE69621649D1 DE 69621649 D1 DE69621649 D1 DE 69621649D1 DE 69621649 T DE69621649 T DE 69621649T DE 69621649 T DE69621649 T DE 69621649T DE 69621649 D1 DE69621649 D1 DE 69621649D1
Authority
DE
Germany
Prior art keywords
cefdinir
pct
date
sec
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69621649T
Other languages
English (en)
Other versions
DE69621649T2 (de
Inventor
Gwan Sun Lee
Young Kil Chang
Jong Pil Chun
Joon Hyung Koh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Original Assignee
Hanmi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019950058694A external-priority patent/KR0174432B1/ko
Priority claimed from KR1019950058695A external-priority patent/KR0174431B1/ko
Application filed by Hanmi Pharmaceutical Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Publication of DE69621649D1 publication Critical patent/DE69621649D1/de
Application granted granted Critical
Publication of DE69621649T2 publication Critical patent/DE69621649T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
DE69621649T 1995-12-27 1996-12-26 Verfahren zur herstellung von cefdinir Expired - Lifetime DE69621649T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019950058694A KR0174432B1 (ko) 1995-12-27 1995-12-27 신규한 결정성 세프디니르 중간체 및 그의 제조방법
KR1019950058695A KR0174431B1 (ko) 1995-12-27 1995-12-27 세프디니르의 제조방법
PCT/KR1996/000250 WO1997024358A1 (en) 1995-12-27 1996-12-26 Process for preparation of cefdinir

Publications (2)

Publication Number Publication Date
DE69621649D1 true DE69621649D1 (de) 2002-07-11
DE69621649T2 DE69621649T2 (de) 2002-09-19

Family

ID=26631527

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69621649T Expired - Lifetime DE69621649T2 (de) 1995-12-27 1996-12-26 Verfahren zur herstellung von cefdinir

Country Status (9)

Country Link
US (1) US6093814A (de)
EP (1) EP0874853B1 (de)
JP (1) JP3948628B2 (de)
AT (1) ATE218572T1 (de)
DE (1) DE69621649T2 (de)
DK (1) DK0874853T3 (de)
ES (1) ES2175167T3 (de)
PT (1) PT874853E (de)
WO (1) WO1997024358A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883247A (en) * 1996-06-10 1999-03-16 Hoffmann-La Roche Inc. Preparation of cephem and isooxacephem derivatives
AT405283B (de) 1997-04-04 1999-06-25 Biochemie Gmbh Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
JP4544692B2 (ja) * 2000-04-13 2010-09-15 大塚化学株式会社 ３−ビニル−セフェム化合物の製造方法
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
ITMI20012364A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Processo di sintesi della cefixima via alchil-o arilsolfonati
JP2005516011A (ja) * 2001-12-13 2005-06-02 ランバクシー ラボラトリーズ リミテッド 結晶二水化セフニディールカリウム
MXPA04010627A (es) * 2002-04-26 2005-02-14 Ranbaxy Lab Ltd Proceso para la preparacion de cefdinir.
ITMI20020913A0 (it) * 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
DE60336331D1 (de) * 2002-08-13 2011-04-21 Sandoz Ag Ein cefdinir-zwischenprodukt
ITMI20022076A1 (it) * 2002-10-01 2004-04-02 Antibioticos Spa Sali di intermedi del cefdinir.
CA2520083A1 (en) * 2003-03-24 2004-10-07 Acs Dobfar S.P.A. Novel crystal of 7-[2-[(2-aminothiazol-4-yl)-2-hydroxyiminoacetamide-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) and method for preparation thereof
WO2004104010A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Crystalline form of cefdinir
US20050137182A1 (en) * 2003-06-02 2005-06-23 Ramesh Dandala Novel crystalline form of cefdinir
US20040242556A1 (en) * 2003-06-02 2004-12-02 Ramesh Dandala Novel crystalline form of cefdinir
US20050059818A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Polymorph of a pharmaceutical
US20050113355A1 (en) * 2003-09-12 2005-05-26 Duerst Richard W. Cefdinir pyridine salt
US20050059819A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Cefdinir pyridine salt
US20060211676A1 (en) * 2004-03-16 2006-09-21 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142261A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142563A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
WO2006010978A1 (en) * 2004-06-30 2006-02-02 Wockhardt Limited Cefdinir polymorphic forms, and imidazole salt
WO2006018807A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Crystalline forms of cefdinir
MX2007006018A (es) * 2004-11-30 2007-06-07 Astellas Pharma Inc Suspension farmaceutica oral novedosa de cristal de cefdinir.
WO2007053723A2 (en) * 2005-10-31 2007-05-10 Teva Pharmaceutical Industries Ltd. Process for the preparation of cefdinir
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
US8466096B2 (en) * 2007-04-26 2013-06-18 Afton Chemical Corporation 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
ITMI20071628A1 (it) * 2007-08-06 2007-11-05 Acs Dobfar Spa Sintesi di 3-alchenilcefalosporine e nuovi intermedi utili ad esse correlati
KR101058135B1 (ko) * 2008-04-04 2011-08-24 대웅바이오 주식회사 세프디니르 합성에 유용한 중간체 및 이를 이용하여세프디니르를 제조하는 방법
CN101481383B (zh) * 2008-12-31 2012-01-11 杭州奥默医药技术有限公司 头孢地尼酸式复盐化合物及制备方法
CN102020664B (zh) * 2010-11-30 2012-12-12 浙江工业大学 一种头孢地尼的合成方法
CN103319503A (zh) * 2013-06-09 2013-09-25 四川方向药业有限责任公司 一种头孢地尼的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162718C (da) * 1982-09-30 1992-05-11 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af 7-substitueret-3-vinyl-3-cephemforbindelser
IL113744A (en) * 1990-11-09 1998-06-15 Eisai Co Ltd History of 3-tufts and their preparation
TW212181B (de) * 1992-02-14 1993-09-01 Hoechst Ag
US5750682A (en) * 1994-07-22 1998-05-12 Antibioticos S.P.A. Glutaryl 7-ACA derivatives and processes for obtaining them

Also Published As

Publication number Publication date
ES2175167T3 (es) 2002-11-16
DK0874853T3 (da) 2002-09-23
JP2000502700A (ja) 2000-03-07
WO1997024358A1 (en) 1997-07-10
JP3948628B2 (ja) 2007-07-25
ATE218572T1 (de) 2002-06-15
US6093814A (en) 2000-07-25
DE69621649T2 (de) 2002-09-19
EP0874853A1 (de) 1998-11-04
EP0874853B1 (de) 2002-06-05
PT874853E (pt) 2002-09-30

Similar Documents

Publication Publication Date Title
ATE218572T1 (de) Verfahren zur herstellung von cefdinir
DE59108707D1 (de) Verfahren zur Herstellung von Oxetanonen
DE69530242D1 (de) Verfahren zur Herstellung von Glutaminsäure durch Fermentation
DE69322708D1 (de) Neues Verfahren zur Herstellung von 7-(substituierten)-9-[(substistuierter Glycyl)amido]-6-demethyl-6-deoxytetracyclinen
ATE226640T1 (de) Verfahren zur herstellung von substituierten arylmilchsäure-haltigen cyclodepsipeptiden mit 24 ringatomen
DE69207429T2 (de) Verfahren zur herstellung von substituierten piperidinen
ATE261953T1 (de) Verfahren zur herstellung von citalopram
DE3576952D1 (de) Verfahren zur herstellung von 4-phenyl-pyrrol-derivaten.
ATE407127T1 (de) Verfahren zur herstellung von beraprost und dessen salzen
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE272637T1 (de) Verfahren zur herstellung einer substituierten imidazopyridinverbindung
DE69513408T2 (de) Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl-lipopeptiden
DE69514512T2 (de) Verfahren zur herstellung von benzopyranderivaten
ATE299147T1 (de) Verfahren zur herstellung von 3-amino-1,5- benzodiazepinderivaten
DE69404476T2 (de) Verfahren zur herstellung von rufloxacin und salze davon
DE69223156T2 (de) Verfahren zur herstellung von enantiomer reinem imidazo (4,5,1-jk) (1,4)-benzodiazepin-2(1h)-thionen
ATE111093T1 (de) Verfahren zur herstellung von enantiomeren von 3- aminchromanderivaten.
DE69416117T2 (de) Verfahren zur herstellung von kondensierten carbapenemderivaten
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1
ATE418629T1 (de) Verfahren zur herstellung von glycinderivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 874853

Country of ref document: EP

Representative=s name: WABLAT LANGE KARTHAUS ANWALTSSOZIETAET, DE